NKG2A+CD56dimCD16br NK cell subset as a potential prognostic marker of response to benralizumab treatment in severe eosinophilic asthmatic patients.
Year: 2024
Type: conference-abstract
Institution: University of Siena
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404097522
